Quantitating drug-target engagement in single cells in vitro and in vivo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitating drug-target engagement in single cells in vitro and in vivo
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume 13, Issue 2, Pages 168-173
Publisher
Springer Nature
Online
2016-12-06
DOI
10.1038/nchembio.2248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mass Cytometry: Single Cells, Many Features
- (2016) Matthew H. Spitzer et al. CELL
- Fluorescent vinblastine probes for live cell imaging
- (2016) Labros G. Meimetis et al. CHEMICAL COMMUNICATIONS
- Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression
- (2015) Eunha Kim et al. BIOCONJUGATE CHEMISTRY
- Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold
- (2015) J. Roux et al. Molecular Systems Biology
- Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
- (2015) Linda Henneman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
- (2015) Jia-Ren Lin et al. Nature Communications
- Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
- (2015) Miles A. Miller et al. Nature Communications
- Label-Free in Situ Monitoring of Histone Deacetylase Drug Target Engagement by Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Biotyping and Imaging
- (2014) Bogdan Munteanu et al. ANALYTICAL CHEMISTRY
- Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin
- (2014) A. M. Laughney et al. Science Translational Medicine
- In vivo imaging of specific drug–target binding at subcellular resolution
- (2014) J. M. Dubach et al. Nature Communications
- Single cell imaging of Bruton's Tyrosine Kinase using an irreversible inhibitor
- (2014) Anna Turetsky et al. Scientific Reports
- BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
- (2013) Y. Shen et al. CLINICAL CANCER RESEARCH
- Determining target engagement in living systems
- (2013) Gabriel M Simon et al. Nature Chemical Biology
- Target validation using chemical probes
- (2013) Mark E Bunnage et al. Nature Chemical Biology
- Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells
- (2013) Charlotte Stadler et al. NATURE METHODS
- Quantitative assessment of single-cell RNA-sequencing methods
- (2013) Angela R Wu et al. NATURE METHODS
- Appraising iniparib, the PARP inhibitor that never was—what must we learn?
- (2013) Joaquin Mateo et al. Nature Reviews Clinical Oncology
- Translational PET imaging research
- (2013) Richard J. Hargreaves et al. NEUROBIOLOGY OF DISEASE
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
- (2013) Greg M. Thurber et al. Nature Communications
- Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
- (2012) Elisabet Wahlberg et al. NATURE BIOTECHNOLOGY
- Positron emission tomography molecular imaging for drug development
- (2011) Paul M. Matthews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intravital Imaging
- (2011) Mikael J. Pittet et al. CELL
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Single-cell dissection of transcriptional heterogeneity in human colon tumors
- (2011) Piero Dalerba et al. NATURE BIOTECHNOLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
- (2010) Dennis A. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-genetic cell-to-cell variability and the consequences for pharmacology
- (2009) Mario Niepel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
- (2009) Sabrina L. Spencer et al. NATURE
- Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes
- (2009) Daniel A Bachovchin et al. NATURE BIOTECHNOLOGY
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
- (2008) Keith A. Menear et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started